bluebird bio
BLUE
$0.90
Share price
0.87%
Change (1 day)
-73.03%
Change (1 year)
Market capitalization of bluebird bio (BLUE)
Market cap: $0.17 Billion
As of June 2024 bluebird bio has a market cap of $0.17 Billion. This makes bluebird bio the world's 7076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of bluebird bio from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.17 B | -34.54% |
| 2023 | $0.26 B | -53.64% |
| 2022 | $0.57 B | -18.08% |
| 2021 | $0.70 B | -75.61% |
| 2020 | $2.87 B | -40.89% |
| 2019 | $4.85 B | -10.52% |
| 2018 | $5.43 B | -37.87% |
| 2017 | $8.74 B | 279.73% |
| 2016 | $2.30 B | -2.86% |
| 2015 | $2.36 B | -20.12% |
| 2014 | $2.96 B | 490.57% |
| 2013 | $0.50 B |
End of Day market cap according to different sources
On May 31st, 2024 the market cap of bluebird bio was reported to be:
$0.17 Billion
$0.17 Billion
$98.77 Million
$99.11 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $122.54 B | 70,278.41% | 🇫🇷 France |
 Merck MRK | $317.96 B | 182,511.58% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.11 B | -32.74% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 6,178.09% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $17.46 M | -89.97% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 8,086.33% | 🇺🇸 USA |